{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:49:34Z","timestamp":1786996174961,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001237","name":"Melville Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C9344\/A10268"],"award-info":[{"award-number":["C9344\/A10268"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C20953\/A18644"],"award-info":[{"award-number":["C20953\/A18644"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006637","name":"School of Pharmacy, University College London","doi-asserted-by":"publisher","award":["CC1078"],"award-info":[{"award-number":["CC1078"]}],"id":[{"id":"10.13039\/501100006637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"BBSRC","doi-asserted-by":"publisher","award":["BB\/L01923X\/1"],"award-info":[{"award-number":["BB\/L01923X\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000704","name":"Royal Society of Chemistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019534","name":"National Marine Sanctuary Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019534","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001317","name":"Swansea University","doi-asserted-by":"publisher","award":["MX30393"],"award-info":[{"award-number":["MX30393"]}],"id":[{"id":"10.13039\/501100001317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001317","name":"Swansea University","doi-asserted-by":"publisher","award":["MX12305"],"award-info":[{"award-number":["MX12305"]}],"id":[{"id":"10.13039\/501100001317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.redox.2025.103924","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:19:56Z","timestamp":1762903196000},"page":"103924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tetrazole-containing naphthalene bis-sulfonamide Keap1-Nrf2 interaction inhibitors with unexpected binding modes"],"prefix":"10.1016","volume":"88","author":[{"given":"Nikolaos D.","family":"Georgakopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep K.","family":"Talapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharadha","family":"Dayalan Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Dikovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma","family":"Gatliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxani","family":"Nikoloudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Schaap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wardby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albena T.","family":"Dinkova-Kostova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kozielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0253-911X","authenticated-orcid":false,"given":"Geoff","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.redox.2025.103924_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.redox.2025.103924_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/acn3.51897","article-title":"Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data","volume":"11","author":"Lynch","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"11","key":"10.1016\/j.redox.2025.103924_bib3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1474-4422(14)70159-0","article-title":"Dimethyl fumarate for relapsing-remitting multiple sclerosis","volume":"13","author":"Burke","year":"2014","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.redox.2025.103924_bib4","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/brain\/awy071","article-title":"KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy","volume":"141","author":"Shekh-Ahmad","year":"2018","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.redox.2025.103924_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120254","article-title":"Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro","volume":"10","author":"Brennan","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.redox.2025.103924_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-07679-7","article-title":"Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy","volume":"7","author":"Georgakopoulos","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.redox.2025.103924_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/med.21925","article-title":"KEAP1-NRF2 protein-protein interaction inhibitors: design, pharmacological properties and therapeutic potential","volume":"43","author":"Crisman","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.redox.2025.103924_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112532","article-title":"Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors","volume":"202","author":"Mou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.redox.2025.103924_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"issue":"17","key":"10.1016\/j.redox.2025.103924_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167035","article-title":"Cation-pi interactions and their functional roles in membrane proteins","volume":"433","author":"Infield","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.redox.2025.103924_bib24","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/acs.chemrev.4c00707","article-title":"The Cation-pi interaction in chemistry and biology","volume":"125","author":"Dougherty","year":"2025","journal-title":"Chem. Rev."},{"issue":"14","key":"10.1016\/j.redox.2025.103924_bib9","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/j.bmc.2013.04.019","article-title":"Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism","volume":"21","author":"Marcotte","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.redox.2025.103924_bib10","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/jm5000529","article-title":"Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis","volume":"57","author":"Jiang","year":"2014","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.redox.2025.103924_bib11","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1021\/acs.jmedchem.5b00185","article-title":"Structure-Activity and structure-property relationship and exploratory in vivo evaluation of the nanomolar Keap1-Nrf2 protein-protein interaction inhibitor","volume":"58","author":"Jiang","year":"2015","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.redox.2025.103924_bib12","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1021\/acsmedchemlett.5b00407","article-title":"Polar recognition group study of Keap1-Nrf2 protein-protein interaction inhibitors","volume":"7","author":"Lu","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"47","key":"10.1016\/j.redox.2025.103924_bib13","doi-asserted-by":"crossref","first-page":"28446","DOI":"10.1074\/jbc.M115.678136","article-title":"Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling","volume":"290","author":"Winkel","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.redox.2025.103924_bib14","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1021\/acs.jmedchem.9b00818","article-title":"Discovery of a potent kelch-like ECH-associated protein 1-Nuclear factor erythroid 2-Related factor 2 (Keap1-Nrf2) protein-protein interaction inhibitor with natural proline structure as a cytoprotective agent against acetaminophen-induced hepatotoxicity","volume":"62","author":"Lu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2025.103924_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2015.08.049","article-title":"Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators","volume":"103","author":"Jain","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"10.1016\/j.redox.2025.103924_bib16","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1021\/acs.jmedchem.8b01133","article-title":"Replacement of a naphthalene scaffold in Kelch-like ECH-associated protein 1 (KEAP1)\/Nuclear factor (Erythroid-derived 2)-like 2 (NRF2) inhibitors","volume":"61","author":"Richardson","year":"2018","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.redox.2025.103924_bib17","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1021\/acs.jmedchem.9b01074","article-title":"Isoquinoline kelch-like ECH-associated protein 1-Nuclear factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) inhibitors with high metabolic stability","volume":"63","author":"Lazzara","year":"2020","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.redox.2025.103924_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/acsmedchemlett.9b00631","article-title":"Synthesis and evaluation of noncovalent naphthalene-based KEAP1-NRF2 inhibitors","volume":"11","author":"Lazzara","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.redox.2025.103924_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115343","article-title":"Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction","volume":"28","author":"Abed","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.redox.2025.103924_bib20","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1021\/acs.jmedchem.2c00457","article-title":"Phenyl bis-sulfonamide Keap1-Nrf2 protein-protein interaction inhibitors with an alternative binding mode","volume":"65","author":"Georgakopoulos","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2025.103924_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114380","article-title":"Structure-activity relationships of 1,4-bis(arylsulfonamido)-benzene or naphthalene-N,N'-diacetic acids with varying C2-substituents as inhibitors of Keap1-Nrf2 protein-protein interaction","volume":"237","author":"Lee","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"10.1016\/j.redox.2025.103924_bib25","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1039\/C5OB00337G","article-title":"A novel transition metal free [bis-(trifluoroacetoxy)iodo]benzene (PIFA) mediated oxidative ipso nitration of organoboronic acids","volume":"13","author":"Chatterjee","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"7","key":"10.1016\/j.redox.2025.103924_bib26","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/ol300325t","article-title":"ipso-Nitration of arylboronic acids with bismuth nitrate and perdisulfate","volume":"14","author":"Manna","year":"2012","journal-title":"Org. Lett."},{"issue":"2","key":"10.1016\/j.redox.2025.103924_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/jm301544x","article-title":"Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives","volume":"56","author":"Sosic","year":"2013","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.redox.2025.103924_bib28","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1080\/00397911.2011.551869","article-title":"A facile synthesis of pyrimidone derivatives and single-crystal characterization of pymetrozine","volume":"42","author":"Wang","year":"2012","journal-title":"Synth. Commun."},{"issue":"8","key":"10.1016\/j.redox.2025.103924_bib29","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1021\/jf047985e","article-title":"Syntheses, antifeedant activity, and QSAR analysis of new oxa(thia)diazolyl 3(2H)-pyridazinones","volume":"53","author":"Cao","year":"2005","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.redox.2025.103924_bib30","series-title":"Pyranouidole Derivatives and the Use Thereof for the Treatment of Hepatitis C Virus Infection or Disease","author":"Condon","year":"2007"},{"issue":"17","key":"10.1016\/j.redox.2025.103924_bib31","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/cbic.201800170","article-title":"Modified peptide inhibitors of the Keap1-Nrf2 protein-protein interaction incorporating unnatural amino acids","volume":"19","author":"Georgakopoulos","year":"2018","journal-title":"Chembiochem"},{"issue":"18","key":"10.1016\/j.redox.2025.103924_bib32","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1021\/acs.jmedchem.5b00602","article-title":"Design, synthesis, and evaluation of triazole derivatives that induce Nrf2 dependent gene products and inhibit the Keap1-Nrf2 protein-protein interaction","volume":"58","author":"Bertrand","year":"2015","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.redox.2025.103924_bib33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.freeradbiomed.2011.10.486","article-title":"Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction","volume":"52","author":"Hancock","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"21","key":"10.1016\/j.redox.2025.103924_bib34","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1039\/c3ob40249e","article-title":"Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity","volume":"11","author":"Hancock","year":"2013","journal-title":"Org. Biomol. Chem."},{"issue":"Pt 4","key":"10.1016\/j.redox.2025.103924_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1107\/S0907444910048675","article-title":"iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM","volume":"67","author":"Battye","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 10","key":"10.1016\/j.redox.2025.103924_bib36","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1107\/S0907444905022626","article-title":"Conserved solvent and side-chain interactions in the 1.35 Angstrom structure of the Kelch domain of Keap1","volume":"61","author":"Beamer","year":"2005","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 4","key":"10.1016\/j.redox.2025.103924_bib37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 4","key":"10.1016\/j.redox.2025.103924_bib38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.redox.2025.103924_bib39","series-title":"Nmrtools.Jl","author":"Waudby","year":"2021"},{"key":"10.1016\/j.redox.2025.103924_bib40","first-page":"16","article-title":"An introduction to one- and two-dimensional lineshape analysis of chemically exchanging systems","author":"Waudby","year":"2023","journal-title":"J. Magnetic Resonance Open"},{"issue":"39","key":"10.1016\/j.redox.2025.103924_bib41","doi-asserted-by":"crossref","first-page":"9744","DOI":"10.1073\/pnas.1716252115","article-title":"Systematic mapping of free energy landscapes of a growing filamin domain during biosynthesis","volume":"115","author":"Waudby","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2025.103924_bib42","unstructured":"Case, D.A., et al., AMBER 2018. 2018: University of California, San Francisco."},{"issue":"1\u20132","key":"10.1016\/j.redox.2025.103924_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/mmi.14953","article-title":"The C-terminal head domain of Burkholderia pseudomallei BpaC has a striking hydrophilic core with an extensive solvent network","volume":"118","author":"Kiessling","year":"2022","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.redox.2025.103924_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"issue":"22","key":"10.1016\/j.redox.2025.103924_bib45","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1158\/0008-5472.CAN-06-2298","article-title":"Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.redox.2025.103924_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101265","article-title":"Detection of thermal shift in cellular Keap1 by protein-protein interaction inhibitors using immunoblot- and fluorescence microplate-based assays","volume":"3","author":"Dayalan Naidu","year":"2022","journal-title":"STAR Protoc"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725004379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725004379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:50:27Z","timestamp":1773816627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725004379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"alternative-id":["S2213231725004379"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103924","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2025-ctf80","asserted-by":"object"}]},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetrazole-containing naphthalene bis-sulfonamide Keap1-Nrf2 interaction inhibitors with unexpected binding modes","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103924"}}